Key points are not available for this paper at this time.
We identified factors associated with the prognosis of HER2-positive patients with BMs. Further research is needed to understand the factors determining the longer survival of HER2-positive/hormone receptor-positive patients.
Laakmann et al. (Mon,) studied this question.